Pallavi Garg | Head, U.S. Oncology Business Unit | Takeda Oncology

Pallavi Garg serves as the Head of U.S. Business Unit, Takeda Oncology. In this role, she leads efforts in the U.S. to advance our capabilities, support a culture of diversity and inclusion, and accelerate the commercialization of our medicines to impact lives of patients impacted by cancer.

Pallavi is an accomplished commercial leader and has nearly two decades of experience focused on Oncology. Previously, Pallavi served as the Head of Global Oncology Products and Pipeline Strategy where she led business development search and evaluation, global marketing for inline brands, insights and analytics, as well as partnered with R&D on the pipeline strategy. She joined Takeda in August 2020 as Vice President and Head of U.S. Oncology Marketing where she led portfolio of marketed brands, digital marketing, and field marketing teams.

Prior to joining Takeda, Pallavi held roles of increasing responsibility at Novartis Oncology and at Bristol Myers Squibb (BMS). During her tenure at Novartis, she oversaw the Global and US launch of Kisqali® and enhanced the long-term strategy for the Breast Portfolio. At BMS, she led consumer marketing for the launch of Opdivo® in the US. Prior to BMS, Pallavi worked in client services for WPP agency network focusing on consumer and OTC brands in South Asia.

Pallavi is a data and digital thought leader and a DE&I champion. She holds an MBA from the Fuqua School of Business at Duke University, North Carolina and a BBA degree from University of Delhi, India.